ACADEMIC STAFF

Diana LIM Gkeok Stzuan

Contact Information

Email
diana_gz_lim@nuhs.edu.sg

Telephone
+65772 6119

Research Themes

  • MOLECULAR PATHOLOGY
  • GYNAECOLOGIC CANCER

Lim Gkeok Stzuan, Diana

ASSISTANT PROFESSOR, NUS
SENIOR CONSULTANT, NUH
Member, NUS CENTRE FOR CANCER RESEARCH (N2CR)

RESEARCH FOCUS

    • Diagnostic molecular pathology
    • Gynaecologic pathology & molecular mechanism underlying gynaecologic cancer

BIOGRAPHY

Dr Diana Lim is a Senior Consultant in the Department of Pathology, National University Hospital and clinical tutor at the Yong Loo Lin School of Medicine, National University of Singapore. Her subspecialty and research interest lies in gynecologic and molecular pathology. She has published research articles, abstracts and book chapters related to gynecological and molecular pathology and is a co-author in the 5th edition of the WHO classification of Female Genital Tumours.

She is the director of Diagnostic Molecular Oncology Centre (DMOC), a CAP accredited laboratory focused on the molecular diagnostics of solid tumours. She is also a member of the Cervical Screen Singapore advisory committee and an affiliate member of the National Cancer Institute of Singapore (NCIS).

Recent Publications

  • Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01). Ngoi NYL, et al. Int J Radiat Oncol Biol Phys. 2020 Oct 9:S0360-3016(20)34384-4. 
  • A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA). Ngoi NYL, et al. Int J Gynecol Cancer. 2020 Aug;30(8):1239-1242. 
  • Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique. Heong V, et al. Cancers (Basel). 2020 Jun 17;12(6):1599. 
  • Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes. Tan TZ, et al. EBioMedicine. 2019 Dec;50:203-210. 
  • Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer. Tan TZ , et al. J Pathol. 2019 Mar;247(3):305-319. 
  • Visual and Modular detection of pathogen nuclei acids with enzyme-DNA molecular complexes. Ho NRY et. al. Nat Commun. 2018;13;9(1):3238
  • Ovarian sex cord stromal tumours: an update in recent molecular advances. Lim D and Oliva E. Patholoy 2018;50(2):178-189.
Scroll to Top